Home/Filings/4/0001628280-24-027714
4//SEC Filing

WASSON GREGORY D 4

Accession 0001628280-24-027714

CIK 0001448431other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:48 PM ET

Size

8.9 KB

Accession

0001628280-24-027714

Insider Transaction Report

Form 4
Period: 2024-06-05
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2024-06-0510,0610 total
    Common Stock (10,061 underlying)
  • Award

    Common Stock

    2024-06-07+13,28647,315 total
  • Exercise/Conversion

    Common Stock

    2024-06-05+10,06134,029 total
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.
  • [F3]On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001188827

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:48 PM ET
Size
8.9 KB